Moneycontrol
HomeNewsIndiaCumulative COVID-19 vaccine doses administered in India cross 208.21 crore-mark: Health ministry
Trending Topics

Cumulative COVID-19 vaccine doses administered in India cross 208.21 crore-mark: Health ministry

Over 3.97 crore children in the age group of 12-14 years have been administered the first dose, while more than 6.14 crore adolescents in the age group 15-18 years have been given the first dose.

August 14, 2022 / 22:09 IST
Story continues below Advertisement

(Representative image: Reuters)

The cumulative number of COVID-19 vaccine doses administered in the country crossed the 208.21 crore-mark on Sunday, with over 20 lakh doses administered till 7 pm, the Union health ministry said. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night.

With 16,24,241 precaution doses administered to those aged 18-59 years till 7 pm, the total number of precaution doses given in this age-group has reached 6,68,15,334 so far, the ministry data said. Those aged 60 years and above have been administered 3.65 crore precaution doses so far.

Story continues below Advertisement

Over 3.97 crore children in the age group of 12-14 years have been administered the first dose, while more than 6.14 crore adolescents in the age group 15-18 years have been given the first dose. The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2 last year.

The next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified comorbid conditions. Vaccination for all people aged more than 45 years began on April 1 last year. The government then decided to expand the ambit of the vaccination drive by allowing everyone above 18 years to be inoculated against Covid from May 1 last year. Vaccination for all people aged more than 45 years began on April 1 last year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show